Novartis AG (SWX:NOVN)
90.63
+0.17 (0.19%)
Apr 17, 2025, 5:31 PM CET
Novartis AG Revenue
In the year 2024, Novartis AG had annual revenue of $51.72B USD with 10.85% growth. Novartis AG had revenue of $13.56B in the quarter ending December 31, 2024, with 15.13% growth.
Revenue
$51.72B
Revenue Growth
+10.85%
P/S Ratio
3.67
Revenue / Employee
$681.60K
Employees
75,883
Market Cap
171.98B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.72B | 5.06B | 10.85% |
Dec 31, 2023 | 46.66B | 3.20B | 7.36% |
Dec 31, 2022 | 43.46B | -513.00M | -1.17% |
Dec 31, 2021 | 43.97B | -5.92B | -11.87% |
Dec 31, 2020 | 49.90B | 1.22B | 2.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Lonza Group AG | 6.57B |
Alcon | 8.98B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.41B |
Sonova Holding AG | 3.71B |
Ypsomed Holding AG | 617.07M |
Novartis AG News
- 1 day ago - Alembic Pharmaceuticals gets USFDA final approval for Carbamazepine tablets USP 200 mg - Business Upturn
- 1 day ago - EWL: A More Political Stable, But Too Expensive Alternative To The U.S. - Seeking Alpha
- 3 days ago - Trump says US pharma tariffs coming in not-too-distant future - Reuters
- 6 days ago - Inflation Might Be Easing But Tech Outlook Still Choppy, Analysts Warn - Benzinga
- 6 days ago - Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages - CNBC
- 6 days ago - Stocks to Watch Friday: JPMorgan, Wells Fargo, BlackRock, Novartis - The Wall Street Journal
- 6 days ago - Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties - Benzinga
- 7 days ago - Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D - Financial Times